| Place of Origin: | China |
|---|---|
| Brand Name: | HNB |
| Certification: | ISO coa |
| Model Number: | HNB-UDCA |
| Minimum Order Quantity: | 1kg |
| Price: | 138 |
| Packaging Details: | 25kg |
| Delivery Time: | 5-10 |
| Payment Terms: | L/C, D/A, D/P, T/T, , MoneyGram |
| Supply Ability: | 50000 |
| Name: | Ursodeoxycholic Acid | MF: | C24H40O4 |
|---|---|---|---|
| MW: | 392.57 | CAS: | 128-13-2 |
| Whatsapp: | +86 152 029 61574 |
Anti Covid-19 UDCA Ursodeoxycholic Acid protect from sars-cov-2 infection by reducing ACE2
| Product Name | Ursodeoxycholic Acid |
| CAS No. | 128-13-2 |
| Molecular Formula | C24H40O4 |
| Molecular Weight | 392.57 |
| Appearance | White Crystalline Powder |
| Assay | 99% |
| Grade | Pharmaceutical Grade |
What is Tauroursodeoxycholic Acid
Tauroursodeoxycholic Acid (TUDCA) has become more and more popular in bodybuilders. Everybody wants to know more about this amazing ingredient. According to Wikipedia, Tauroursodeoxycholic Acid (TUDCA) is a bile acid. And it is the taurine conjugate form of ursodeoxycholic acid (UDCA). Black bear bile has a rich content of UCDA, which has been used in traditional Chinese medicine to treat liver and eye related illnesses for centuries. Modern researches have found TUDCA could promote natural bile flow and inhibit the formation of toxic stero metabolites, which could protect the liver from the high toxic levels.
How Tauroursodeoxycholic Acid Works
Sters are infamous for inhibiting the production and flow of bile from the liver. This effect is known as cholestasis. Build up of high toxic levels in the liver from toxic sted metabolites can lead to cell damage and even death. As an endogenous bile acid, TUDCA encourages natural bile flow and inhibits the formation of toxic stero metabolites - the stuff that causes bile blockage in the first place!
Tauroursodeoxycholic Acid Benefits for Treatment of Cholestasis
Cholestasis is a condition in which bile flow from the liver is distrupted in some manner. UDCA and TUDCA are currently one of the first lines of treatment for a variety of cholestatic syndromes. A 2003 study showed that TUDCA is a noncompetitive inhibitor of ster glucuronidation in vivo and in vitro. This means fewer toxic metabolites will be made in the first place! And, TUDCA may also increase the excretion of any glucuronide metabolites that do get formed, so they will not be around long enough in the liver to start down regulating any bile acid transporters.
Tauroursodeoxycholic Acid Side Effects
There is no scientific results showing the side effects of taking TUDCA and it seems safe to the most adults.
Tauroursodeoxycholic Acid Dosage
As with any supplement, it is should consult your doctor before using, Remember that the following is only a general guide. It is recommended that individuals take 250mg one or two times daily as needed.
Where to buy high quality Tauroursodeoxycholic Acid
Henan Steeda Industrial Co.,Ltd (Tiny Grass Botanicals Co.,Ltd) is a manufacturer of botanical extract and experienced supplier of Amino Acids & its Derivatives, Vitamins & its Derivatives, Sweeteners, Minerals, Sports Nutrition, Nootropics and Cosmetic Ingredients. Tauroursodeoxycholic Acid is one of our most competitive products with stocks available all year round. By providing superior quality, we establish long-term relationships with our clients.
Research shows that the reason why COVID-19 can invade the human body is mainly through the ACE2 receptor. Ursodeoxycholic acid can turn off the ACE2 receptor, which means that the door of virus invasion into cells is closed.
Moreover, since ursodeoxycholic acid is targeted at host cells rather than the virus itself, it can even prevent new variants of COVID-19 in the future and other coronaviruses that may appear.
In order to further study the role of ursodeoxycholic acid, researchers carried out a series of experiments. The experiment shows that:
Ursodeoxycholic acid can protect cells from COVID-19 infection in vitro.
In animal experiments, ursodeoxycholic acid can effectively prevent hamsters from being infected with COVID-19.
Eight healthy volunteers were recruited to receive ursodeoxycholic acid treatment. The results showed that the level of ACE2 in nasal cells of the volunteers after treatment decreased.
In addition, the researchers also searched a foreign COVID-19 case database specifically for patients with liver disease. The data results show that patients who have used ursodeoxycholic acid to treat liver disease are less likely to develop severe disease or be hospitalized after being infected with COVID-19.
For some people who cannot be vaccinated, the research findings may become their "gospel". Fotios Sampaziotis, the corresponding author of the paper, said that vaccines play a protective role by strengthening the immune system to recognize and eliminate viruses. But the vaccine is not effective for everyone, such as some people with weak immune systems. Vaccines are not suitable for everyone. In addition, the virus is also constantly mutating, resulting in reduced protective effect of the vaccine. This research has found a way to close the door of COVID-19 entering human cells, which can prevent virus invasion from the beginning and protect the human body from infection.
In addition, more importantly, ursodeoxycholic acid is a common drug for liver disease, which has passed the patent period, so ursodeoxycholic acid can be imitated in large quantities.
